Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961
Commentary on and reprint of EPIC (Evaluation of 7E3 for the Prevention of Ischemic Complications) Investigators, The, Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, in New England Journal of Medicine (1994) 330:956–961
复制标题
EPIC(评估 7E3 预防缺血性并发症)研究人员的评论和重印,在高风险冠状动脉血管成形术中使用针对血小板糖蛋白 IIb/IIIa 受体的单克隆抗体,新英格兰医学杂志 (1994) 330:956–961
DOI:
10.1016/b978-012448510-5/50164-3
复制
发表时间:
2000
影响因子:
2.3
通讯作者:
E. Henderson
中科院分区:
文献类型:
--
作者:
M. Lichtman;J. Spivak;L. Boxer;S. Shattil;E. Henderson
DOI:
10.1002/ccd.1810120406
发表时间:
1986
期刊:
Catheterization and cardiovascular diagnosis
影响因子:
--
作者:
Spadaro,JJ;Ludbrook,PA;Tiefenbrunn,AJ;Kurnik,PB;Jaffe,AS
通讯作者:
Jaffe,AS
DOI:
10.1016/0002-9149(87)90479-6
发表时间:
1987
期刊:
The American journal of cardiology
影响因子:
--
作者:
Harker,LA
通讯作者:
Harker,LA
影响因子:
24
作者:
Wall,TC;Califf,RM;Ellis,SG;Sigmon,K;Kereiakes,D;George,BS;Samaha,J;Sane,D;Stump,DC;Stack,RS
通讯作者:
Stack,RS